Catheter Precision, Inc. VTAK · Stock Open Catheter Precision, Inc. in new tab
Catheter Precision, Inc. Analysis (VTAK)
Is Catheter Precision, Inc. a good investment? Catheter Precision, Inc. (VTAK) is currently trading at 0.1510 USD.
In terms of valuation, the stock trades at a P/E ratio of 0.03. This relatively low multiple may signal that Catheter Precision, Inc. is undervalued compared to historical market norms.
Earnings Schedule: Catheter Precision, Inc. is expected to release its next earnings report on Nov. 12, 2026. The market consensus estimate for Forward EPS is -3.75.
Investor FAQ
Does Catheter Precision, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Catheter Precision, Inc.?
Catheter Precision, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 12, 2026. The company currently has a trailing EPS of -68.40.
Company Profile
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures. Catheter Precision, Inc. was formerly known as Catheter Robotics Inc. The company is based in Fort Mill, South Carolina.
| Split Date | Split Ratio to 1 |
|---|---|
| Nov. 17, 2020 | 1:25 |
| Oct. 3, 2022 | 1:50 |
| July 15, 2024 | 1:10 |
| Aug. 15, 2025 | 1:20 |
| Oct. 5, 2026 | 1:10 |
Community Discussion